基于个人生理学的快速预测数字双胞胎对于最小有效的芬太尼剂量是否比标准实践更好:试点研究协议
Milena Cukic1, Simon Annaheim2, Flora Bahrami2,3
1Laboratory for Biomimetic Membranes and Textiles, Empa Swiss Federal Labs for Materials Science and Technology, St. Gallen, Switzerland milena.cukic@gmail.com.
BMJ open
|September 24, 2024
概括
本研究概述了一项协议,用于验证数字双胞胎在晚期癌症患者个性化芬太尼剂量. 这种方法旨在改善疼痛管理和减少与阿片类药物治疗相关的风险.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 医疗技术 医疗技术 医学技术
背景情况:
- 晚期癌症患者经常经历严重的疼痛,用阿片类药物,如芬太尼.
- 透皮芬太尼提供连续的,非侵入性的药物输送,但由于其狭窄的治疗指数,需要精确的剂量.
- 目前的阿片类药物轮换工具缺乏个性化,无法考虑影响芬太尼的有效性和安全性的患者特定因素.
研究的目的:
- 开发和验证一个用于优化个人芬太尼剂量的临床协议,使用基于物理的数字双胞胎 (PBDT).
- 加强针对晚期癌症患者的个性化透皮芬太尼治疗,以提高疗效和安全性.
- 通过严格的验证,使个性化阿片类药物剂量策略更接近临床实践.
主要方法:
- 开发一种临床协议,将基于物理的数字双胞胎 (PBDT) 与患者特定的临床和生理数据相结合.
- 通过治疗药物监测,呼吸动态,疼痛水平评估和不良事件监测验证PBDT预测.
- 设计一个实验性协议,严格评估PBDT引导的皮肤透过芬太尼剂量的性能.
主要成果:
- 已经开发出了PBDT引导的芬太尼剂量的临床方案.
- 研究方案包括全面的监测,以验证PBDT的准确性和临床效用.
- 该研究准备在2024年夏末启动研究.
结论:
- 基于物理的数字双胞胎技术对晚期癌症的个性化芬太尼剂量有希望.
- 通过治疗药物监测和其他评估进行临床验证对于PBDT的采用至关重要.
- 这项工作代表了在临床环境中实施个性化阿片类药物治疗的重要一步.
更多相关视频
相关概念视频
01:26Pharmacokinetic Models: Comparison and Selection Criterion
49
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
49
01:21Factors Affecting Drug Response: Overview
1.9K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
1.9K
00:57Physiological Pharmacokinetic Models: Blood Flow-Limited Versus Diffusion-Limited Models
70
Physiological pharmacokinetic models, often called flow-limited or perfusion models, typically assume a swift drug distribution between tissue and venous blood, creating a rapid drug equilibrium. This premise is based on the idea that drug diffusion is extremely fast, and the cell membrane presents no barrier to drug permeation. In this scenario, where no drug binding occurs, the drug concentration in the tissue equals that of the venous blood leaving the tissue. This greatly simplifies the...
70
01:11Renal Failure: Dose Adjustments
68
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
68
01:20Compartment Models: Two-Compartment Model
5.3K
The two-compartment model divides the body into central and peripheral compartments to account for varying blood perfusion rates among organs and tissues, affecting drug distribution. The central compartment includes blood and highly perfused tissues with rapid drug distribution, while the peripheral compartment contains tissues with slower drug distribution. After a single IV bolus dose, the drug concentration is high in plasma and low in tissues. The drug distribution between compartments...
5.3K
01:19One-Compartment Open Model for IV Bolus Administration: General Considerations
170
The one-compartment model is a pharmacokinetic tool that models the body as a single, uniform compartment, facilitating the understanding of drug distribution and elimination. This model is particularly beneficial for intravenous (IV) bolus administration, where the drug rapidly circulates throughout the body.
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant,...
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant,...
170